SCHEMBL6838438

SCHEMBL6838438

Cc1cccc(N)c1NCCC#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.46
THRB P10828 1/20 0.42
GAA P10253 4/20 0.39
ALDH1A1 P00352 3/20 0.39
CD44 P16070 1/20 0.38
CYP3A4 P08684 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 2/20 0.33
PIK3CA P42336 1/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPK1 P28482 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11281008 0.88 HTT (0.53) HTTTHRBGAAALDH1A1TDP1
SCHEMBL3635788 0.79 CD44 (0.43) HTTGAAALDH1A1CD44CYP3A4
SCHEMBL6834041 0.77 HTT (0.42) HTTTHRBGAAALDH1A1CD44
SCHEMBL6840595 0.77 HTT (0.46) HTTTHRBGAAALDH1A1CD44
SCHEMBL7138488 0.76 KAT2B (0.47) HTTALDH1A1CD44CYP3A4TDP1
SCHEMBL13497804 0.74 CD44 (0.46) HTTGAAALDH1A1CD44CYP3A4
SCHEMBL11575405 0.72 HTT (0.49) HTTTHRBGAAALDH1A1CYP3A4
SCHEMBL29691338 0.72 HTT (0.49) HTTTHRBGAAALDH1A1CYP3A4
SCHEMBL23908718 0.72 GAA (0.40) HTTTHRBGAAALDH1A1TDP1
SCHEMBL2228032 0.72 HTT (0.67) HTTTHRBGAAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6759503-B2 CYANOETHYLATED TOLUENEDIAMINES (CNTDAS), PROCESSES FOR SYNTHESIZING THEM, AND COMPOSITIONS CONTAINING THEM THE CNTDAS ARE PARTICULARLY SUITABLE FOR USE AS LATENT CURING AGENTS FOR EPOXY RESINS. AIR PRODUCTS AND CHEMICALS, INC. 2004-07-06 US claimed
US-20030144540-A1 N-cyanoethylated ortho and meta toluenediamine compositions and process for making them STARNER WILLIAM EDWARD (US) 2003-07-31 US claimed
US-6593487-B1 Latent curing agents for epoxy resins AIR PRODUCTS AND CHEMICALS, INC. 2003-07-15 US claimed
EP-1321459-A2 N-Cyanoethylated ortho and meta toluenediamine compositions and process for making them AIR PRODUCTS AND CHEMICALS, INC. (US) 2003-06-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144540-A1 N-cyanoethylated ortho and meta toluenediamine compositions and process for making them DNMT1, PNMT, TET1 HTT 2214/4885THRB 2814/4885GAA 2226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.